# Repurposing Lithium for Parkinson's Disease: a RCT

> **NCT06339034** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **State University of New York at Buffalo** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Lithium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06339034
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-03
- **Primary completion:** 2025-12
- **Final completion:** 2026-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06339034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06339034, "Repurposing Lithium for Parkinson's Disease: a RCT". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06339034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*